Plasma ADMA associates with all-cause mortality in renal transplant recipients.
about
Asymmetric Dimethylarginine and Its Relation As a Biomarker in Nephrologic DiseasesMetabolomic Profiling in Individuals with a Failing Kidney AllograftADMA predicts major adverse renal events in patients with mild renal impairment and/or diabetes mellitus undergoing coronary angiographyAsymmetric dimethylarginine and all-cause mortality: a systematic review and meta-analysis.Symmetric dimethylarginine (SDMA) outperforms asymmetric dimethylarginine (ADMA) and other methylarginines as predictor of renal and cardiovascular outcome in non-dialysis chronic kidney disease.The role of L-arginine/L-homoarginine/nitric oxide pathway for aortic distensibility and intima-media thickness in stroke patients.
P2860
Plasma ADMA associates with all-cause mortality in renal transplant recipients.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Plasma ADMA associates with all-cause mortality in renal transplant recipients.
@ast
Plasma ADMA associates with all-cause mortality in renal transplant recipients.
@en
type
label
Plasma ADMA associates with all-cause mortality in renal transplant recipients.
@ast
Plasma ADMA associates with all-cause mortality in renal transplant recipients.
@en
prefLabel
Plasma ADMA associates with all-cause mortality in renal transplant recipients.
@ast
Plasma ADMA associates with all-cause mortality in renal transplant recipients.
@en
P2093
P2860
P1433
P1476
Plasma ADMA associates with all-cause mortality in renal transplant recipients.
@en
P2093
Anne-Roos S Frenay
Bibiana Beckmann
Dimitrios Tsikas
Else van den Berg
Gerjan Navis
Martin Feelisch
Martin H de Borst
Stephan J L Bakker
P2860
P2888
P304
P356
10.1007/S00726-015-2023-0
P577
2015-06-16T00:00:00Z